Ampametry None

Ampametry is a startup company established in 2019 that specializes in neuropsychiatric drugs using AMPA-PET technology. Their focus is on central nervous system drug discovery and they support preclinical and clinical trials using this technology.

Headquarters: Yokohama-shi, Kanagawa, Japan